Ubs Global Asset Management Americas »

Iovance Biotherapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 180k 8.13
2023-09-30 $827k 182k 4.55
2023-06-30 $783k 128k 6.11
2023-03-31 $783k 128k 6.11
2022-12-31 $819k 128k 6.39
2022-09-30 $1.2M 128k 9.58
2022-06-30 $1.7M 157k 11.04
2022-03-31 $3.6M 218k 16.65
2021-12-31 $3.4M 178k 19.09
2021-09-30 $4.3M 174k 24.66
2021-06-30 $4.6M 176k 26.02
2021-03-31 $9.8M 310k 31.66
2020-12-31 $14M 311k 46.40
2020-09-30 $9.5M 290k 32.92
2020-06-30 $8.0M 290k 27.45
2020-03-31 $7.9M 263k 29.94
2019-12-31 $3.0M 109k 27.68
2019-09-30 $1.5M 82k 18.20
2019-06-30 $1.5M 62k 24.52
2019-03-31 $447k 47k 9.51
2018-12-31 $416k 47k 8.85
2018-09-30 $409k 36k 11.25
2018-06-30 $465k 36k 12.80
2018-03-31 $614k 36k 16.90
2017-12-31 $82k 10k 8.00
2017-09-30 $80k 10k 7.75
2017-06-30 $75k 10k 7.35